Company · CIK 0001347178
Vanda Pharmaceuticals Inc.
VNDASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$4.57+$0.01 (+0.219%)
VNDA · Last trade
- Prev close
- $4.56
- Range (28d)
- $4.52 – $5.21
On the record
Recent filings
- SCHEDULE 13G/AVNDAVanda Pharmaceuticals Inc.0001104659-26-115112 · 20.0 KBSEC(opens sec.gov)
- SCHEDULE 13GVNDAVanda Pharmaceuticals Inc.0001104659-26-098866 · 15.3 KBSEC(opens sec.gov)
- SCHEDULE 13GVNDAVanda Pharmaceuticals Inc.0001167557-26-000170 · 8.8 KBSEC(opens sec.gov)
- 10-QVNDAQuarterly update0001628280-26-053855 · 7.2 MBSEC(opens sec.gov)
- 8-KVNDACurrent report0001628280-26-053308 · 382.1 KBSEC(opens sec.gov)
- 8-KVNDACurrent report0001628280-26-041298 · 166.6 KBSEC(opens sec.gov)
- 10-QVNDAQuarterly update0001628280-26-031667 · 6.4 MBSEC(opens sec.gov)
- 8-KVNDACurrent report0001628280-26-031241 · 339.6 KBSEC(opens sec.gov)
- 8-KVNDACurrent report0001628280-26-026642 · 240.0 KBSEC(opens sec.gov)
- 8-KVNDACurrent report0001628280-26-023222 · 144.3 KBSEC(opens sec.gov)
Insiders
- Baroldi PaoloSVP & Chief Medical Officer
- BATE KENNETHDirector
- Birznieks GuntherSVP, Business Development
- BLAIR JAMES C10% Owner
- CARE CAPITAL II LLC10% Owner
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Chrousos PhaedraDirector
- Clark William DSr. VP, Chief Business Officer
- COLA MICHAEL FDirector
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
Tickers
Addresses
business
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
mailing
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
Same industry